AGVHD
Clinical trials for AGVHD explained in plain language.
Never miss a new study
Get alerted when new AGVHD trials appear
Sign up with your email to follow new studies for AGVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double donor transplant trial aims to boost survival in blood cancer patients
Disease control Recruiting nowThis study tests whether using two different stem cell donors together can help people with certain blood cancers (like leukemia and myelodysplastic syndromes) live longer without their cancer coming back. About 36 participants will receive a transplant from a half-matched family…
Matched conditions: AGVHD
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 06:21 UTC
-
New drug aims to stop immune attack after stem cell transplants
Disease control Recruiting nowThis study tests a new drug called BPC2001 to prevent acute graft-versus-host disease (aGVHD) in people receiving a stem cell transplant from a half-matched donor. aGVHD is a serious condition where donor immune cells attack the patient's body. The trial includes 50 adults with b…
Matched conditions: AGVHD
Phase: PHASE2 • Sponsor: BioPhoenix Co., Ltd. • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC